Hap Trading, LLC Seres Therapeutics, Inc. Call Options Transaction History

Hap Trading, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$5.09 - $9.05 $61,080 - $108,600	12,000 New	12,000 $0
Q1 2022 May 12, 2022	SELL	$6.3 - $8.84 $261,450 - $366,860	-41,500 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$6.02 - $11.43 $249,829 - $474,345	41,500 New	41,500 $39,000
Q2 2021 Aug 11, 2021	SELL	$18.46 - $24.36 $208,598 - $275,268	-11,300 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$17.66 - $28.92 $199,558 - $326,796	11,300 New	11,300 $23,000
Q4 2020 Feb 16, 2021	SELL	$23.25 - $37.73 $3.7 Million - $6 Million	-159,000 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$3.74 - $28.74 $594,660 - $4.57 Million	159,000 New	159,000 $252,000

46.3M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $114M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.